Regeneron Pharmaceuticals Inc. logo

REGN

Regeneron Pharmaceuticals Inc.

$781.49
-1.48%
Last updated 6:08 AM
Regeneron Pharmaceuticals Inc logo

Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc is a Biotechnology company listed on NASDAQ NMS - GLOBAL MARKET.

Industry
Biotechnology
Exchange
NASDAQ NMS - GLOBAL MARKET
Market Cap
$80.5B
P/E Ratio
18.6
Cash on Hand
$8.5B(positive)
Shares Outstanding
104.8M shares
Currency
USD
Visit website →

About

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.

via Wikipedia →

Earnings (EPS)

QuarterEPS EstimateEPS Actual
Q2 2026$10.47$14.29
Q1 2026$9.12$9.47
Q4 2025$10.83$11.44
Q3 2025$9.78$11.83

Financial Highlights

The basics, explained simply — no finance degree required.

52-Week Range
$541.00 – $859.34

The lowest and highest price this stock has traded at over the past year.

Dividend Yield
0.47%

How much this stock pays you back each year, just for holding it — as a % of the share price.

Profit Margin
27.9%

How much of every $1 in sales turns into actual profit. Higher generally means a healthier business.

Revenue Growth
+9.3%

How much the company's sales grew compared to a year ago.

Volatility (Beta)
0.13

How much this stock tends to swing compared to the overall market. Above 1 means it typically moves more than the market (higher risk, higher potential reward); below 1 means it's historically calmer.

Analyst Insights

Analyst Consensus
Buy

Based on 38 analysts

Next Earnings
Oct 26, 2026
Similar Companies

Insider Activity

Recent buys and sells by company executives and directors — publicly disclosed, as required by law.

Zoghbi Huda Y
Aug 10, 2026 • $376.69/share
Bought 800
Zoghbi Huda Y
Aug 10, 2026 • $800.00/share
Sold 800
Zoghbi Huda Y
Aug 10, 2026
Sold 800
Guarini Kathryn
Aug 10, 2026 • $719.37/share
Bought 400
Guarini Kathryn
Aug 10, 2026 • $800.00/share
Sold 400
Guarini Kathryn
Aug 10, 2026
Sold 400

Recent News